Cargando…
Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
Nonsteroidal anti-inflammatory drugs (NSAIDs) have been proposed for prevention and treatment of a variety of human cancers. Piroxicam, in particular, has been recently shown to exert significant anti-tumoral activity in combination with cisplatin (CDDP) on mesothelioma cells. However, the mechanism...
Autores principales: | Verdina, Alessandra, Cardillo, Irene, Nebbioso, Angela, Galati, Rossella, Menegozzo, Simona, Altucci, Lucia, Sacchi, Ada, Baldi, Alfonso |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2412853/ https://www.ncbi.nlm.nih.gov/pubmed/18498639 http://dx.doi.org/10.1186/1479-5876-6-27 |
Ejemplares similares
-
Retraction Note: Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
por: Verdina, Alessandra, et al.
Publicado: (2022) -
Synergistic effect of gefitinib and rofecoxib in mesothelioma cells
por: Stoppoloni, Daniela, et al.
Publicado: (2010) -
Apoptosis Induced by Piroxicam plus Cisplatin Combined Treatment Is Triggered by p21 in Mesothelioma
por: Baldi, Alfonso, et al.
Publicado: (2011) -
Piroxicam and intracavitary platinum-based chemotherapy for the treatment of advanced mesothelioma in pets: preliminary observations
por: Spugnini, Enrico P, et al.
Publicado: (2008) -
Piroxicam-β-Cyclodextrin: A GI Safer Piroxicam
por: Scarpignato, C
Publicado: (2013)